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Abstract
Background: Adequate pain assessment is critical for evaluating the efficacy of analgesic treatment in clinical practice and
during the development of new therapies. Yet the currently used scores of global pain intensity fail to reflect the diversity of
pain manifestations and the complexity of underlying biological mechanisms. We have developed a tool for a standardized
assessment of pain-related symptoms and signs that differentiates pain phenotypes independent of etiology.
Methods and Findings: Using a structured interview (16 questions) and a standardized bedside examination (23 tests), we
prospectively assessed symptoms and signs in 130 patients with peripheral neuropathic pain caused by diabetic
polyneuropathy, postherpetic neuralgia, or radicular low back pain (LBP), and in 57 patients with non-neuropathic (axial)
LBP. A hierarchical cluster analysis revealed distinct association patterns of symptoms and signs (pain subtypes) that
characterized six subgroups of patients with neuropathic pain and two subgroups of patients with non-neuropathic pain.
Using a classification tree analysis, we identified the most discriminatory assessment items for the identification of pain
subtypes. We combined these six interview questions and ten physical tests in a pain assessment tool that we named
Standardized Evaluation of Pain (StEP). We validated StEP for the distinction between radicular and axial LBP in an
independent group of 137 patients. StEP identified patients with radicular pain with high sensitivity (92%; 95% confidence
interval [CI] 83%–97%) and specificity (97%; 95% CI 89%–100%). The diagnostic accuracy of StEP exceeded that of a
dedicated screening tool for neuropathic pain and spinal magnetic resonance imaging. In addition, we were able to
reproduce subtypes of radicular and axial LBP, underscoring the utility of StEP for discerning distinct constellations of
symptoms and signs.
Conclusions: We present a novel method of identifying pain subtypes that we believe reflect underlying pain mechanisms.
We demonstrate that this new approach to pain assessment helps separate radicular from axial back pain. Beyond
diagnostic utility, a standardized differentiation of pain subtypes that is independent of disease etiology may offer a unique
opportunity to improve targeted analgesic treatment.
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Introduction
Conventional measures of chronic pain either rely on global
scores to assess pain intensity and determine treatment success, or
they employ surrogate markers of improvement such as gain of
function and quality of life [1]. However, rating overall pain
intensity or documenting functional improvement does not take
into account the neurobiological complexity of pain [2–5]. Global
assessments fail to reflect basic characteristics of the pain, for
example, if pain occurs spontaneously or in response to external
stimuli. Likewise, evaluations based on descriptions of the pain’s
sensory properties (pain qualities) [6], its unpleasantness, or other
psychological dimensions [7] do not give any insight into its
underlying mechanisms. We argue that inadequate pain assess-
ment contributes to the difficulty of providing patients with
targeted pain treatment, resulting in a high number of nonre-
sponders. It also hampers the measurement of treatment efficacy
and the development of new analgesic therapies.
Clinical pain is generally classified as acute or chronic and is
divided into two major categories: inflammatory and neuropathic
pain. Combinations of inflammatory and neuropathic pain do
occur, for example, in postsurgical [3], cancer [4] and back pain
[8]. Distinct mechanisms are responsible for the development and
the persistence of clinical pain. Tissue damage causes the release of
inflammatory mediators, which leads to sensitization of peripheral
nociceptors. Enhanced afferent input from sensitized afferents and
the spread of cytokines from inflamed tissue increase the
excitability of neurons in the central nervous system (central
sensitization). As a result, normally innocuous stimuli now produce
pain (allodynia), and an area of heightened pain sensitivity
(hyperalgesia) expands beyond the site of the inflammation [2,9].
Neuropathic pain—defined as pain arising as a direct consequence
of a lesion or disease affecting the somatosensory system [10]—
also involves abnormal (ectopic) activity of primary sensory
neurons and central sensitization. Altered gene transcription in
primary sensory and spinal neurons, changes in synaptic
connectivity, a shift from inhibition to enhanced facilitation of
sensory transmission in the spinal cord, and a marked neuroim-
mune response are further elements of the complex process that
ultimately leads to persistent neuropathic pain [11,12].
A global pain intensity score obliterates differences in pain-
related symptoms or signs that might indicate the relative
contribution of particular mechanisms to a patient’s pain. A
clinically more useful pain assessment would associate particular
symptoms and signs that constitute the pain phenotype of a patient
with the underlying mechanisms and in this way reveal potential
targets for pharmacological intervention. Such an assessment
would provide a specific measure of treatment success or failure. It
would also allow tailoring analgesic therapy to the needs of the
individual patient by selecting and combining drugs with proven
efficacy against operating mechanisms. However, it is currently
not possible to determine pain mechanisms in patients directly
[13,14]. Techniques such as quantitative sensory testing, nerve
conduction studies and evoked potentials, functional imaging, skin
biopsies, and genetic screening are research tools that provide
valuable information about the neurobiology of pain. But these
investigations are labor-intensive, expensive, and require a level of
technical expertise that is available only at highly specialized
centers; they are not suitable for routine evaluation of a patient’s
pain or application in large clinical trials on analgesic efficacy.
We hypothesize that pain mechanisms are reflected and
therefore recognizable by the specific patterns of pain-related
symptoms and clinical signs they elicit [15,16]. For example,
ectopic excitability in injured sensory nerve fibers is likely to
produce intermittent episodes of spontaneous pain, whereas
facilitation of synaptic transmission in the dorsal horn of the
spinal cord leads to pain evoked by light touch. In the present
study, we have developed a tool for the assessment of neuropathic
pain that is designed to differentiate subtypes of pain based on
particular constellations of symptoms and signs, and tested its
utility for the distinction between radicular and axial back pain.
Methods
We conducted the study in two parts. In Part 1, we prospectively
evaluated a comprehensive range of pain-related symptoms and
signs in order to develop a standardized clinical tool for the
differentiation of pain subtypes. We performed this part of the
study at the Massachusetts General Hospital Center for Pain
Medicine in Boston, Massachusetts, United States, from March
2002 until October 2004. Part 2 of the study, in which we
validated the pain assessment tool, was carried out between
January 2006 and November 2007 at the Back Pain Triage Clinic
and the Neurosurgical Outpatient Clinic of Addenbrooke’s
Hospital, Cambridge, United Kingdom. The study was conducted
according to the principles expressed in the Declaration of
Helsinki. The study protocols were approved by the Human
Research Committee of Massachusetts General Hospital (2001-P-
000872) and the National Health Service Research Ethics
Committee in Cambridge (05/Q0108/477). All patients gave
written informed consent.
Part 1. Development
Participants. We recruited patients with painful diabetic
polyneuropathy (DN), postherpetic neuralgia (PHN), or chronic
low back pain (LBP) through physician referrals and
advertisements. Patients with DN had clinically documented
diabetes mellitus, reported distal abnormal sensations such as
numbness and tingling in their feet and lower legs, and exhibited
symmetric sensory deficits and absent ankle jerk reflexes upon
examination. If available, records of impaired nerve conduction
were used to supplement the clinical diagnosis of a neuropathy,
but electrophysiological evaluation was not an inclusion criterion.
Patients with PHN had persistent pain in an area previously
affected by an eruption of herpes zoster; altered sensation,
scarring, and changes in skin pigmentation were considered
additional signs supporting the diagnosis of PHN. We divided
patients with chronic LBP in two groups: with (radicular LBP) and
without (axial LBP) clinical signs of nerve root involvement,
including sensory or motor deficits in the leg and a diminution or
loss of tendon reflexes. In taking the history of patients with LBP,
we asked about the primary location of the pain and whether it
radiated into the leg. We also explored whether body positions
such as sitting or activities such as weight-bearing or walking
elicited or enhanced the pain. If available, we considered results
from spinal imaging and further investigations such as
electromyography for the diagnostic decision.
We included patients who met all of the following criteria: pain
duration $3 mo, average global pain intensity in the week prior to
enrollment $6 on a numerical rating scale (NRS) from 0 to 10,
age $18 y, and ability to give written informed consent. Patients
with a severe medical or psychiatric illness, another painful
disorder or neurological disease that might have interfered with
the pain assessment, or a local infection were excluded. The
patients were allowed to continue their previously prescribed
analgesic treatment.
Symptoms and Signs Define Pain Subtypes
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Assessment of symptoms and signs. We evaluated pain-
related symptoms and signs and somatosensory function through a
structured interview followed by a standardized physical
examination. The interview consisted of 16 questions exploring
46 items; the physical examination included 23 bedside tests that
provided information about 39 items (see Table S1).
In the interview, we explored the location and temporal
characteristics of the pain and its dependence on external
stimulation. To determine the sensory quality of the pain, we first
asked the patients to characterize the pain in their own words. We
then offered a choice of one or more descriptions from the
following list: throbbing, pounding, pulsating, shooting, radiating,
cramping, squeezing, stabbing, sharp, aching, dull, painful pins
and needles, stinging, burning, or hot. We also asked the patients
to report unpleasant nonpainful sensations (dysesthesia) and
describe the characteristics of these sensations. The patients
indicated the intensity of each specific aspect of their pain using an
11-point NRS from 0 (no pain) to 10 (maximum imaginable pain)
(see Table S1).
The physical examination was designed to involve tests that
would be readily available for a bedside assessment, without the
need for advanced or expensive technical equipment. We looked
for cutaneous changes indicative of an autonomic nervous system
disorder. Two von Frey filaments (North Coast Medical, Morgan
Hill, California, United States) were employed to examine the
response to punctate tactile stimulation: a filament of low strength
(2 g) applied a force above the detection threshold for touch on
intact skin; a filament of high strength (26 g) elicited a prickly, but
normally painless sensation [17,18]. Each filament was applied
four times; the result was considered positive when three
stimulations produced a response. The response to light pressure
was tested using the eraser end of a pencil, which was applied so as
just to indent the skin for 10 s. To assess the pressure sensitivity of
deep tissues, the examiner applied firm pressure using her or his
thumb. A soft brush (width 1 cm) was lightly moved over the skin
at 3–5 cm per second in a constant direction to assess the response
to dynamic tactile stimulation. To examine the response to
pinprick, we used a standard safety pin and indented the skin four
times with enough pressure to elicit a painful response on normal
skin without leaving a mark. We recorded decreased or excess
pinprick-evoked pain, respectively, when the pain was reduced or
increased compared to the response to pinprick in an adjacent or
contralateral unaffected area in three out of four stimulations. The
sense of vibration was tested with a standard tuning fork (128 Hz).
The tuning fork was applied over the first metatarsophalangeal
joint for patients with DN, over the spinous process of a vertebra
belonging to the spinal segment affected by PHN, or the L5
spinous process and the first metatarsophalangeal joint for patients
with LBP. We employed cylindrical brass bars (diameter 1 cm)
kept at 20uC to produce a nonpainful cold stimulus and 40uC for a
nonpainful warm stimulus, respectively [18,19]; each temperature
probe was applied for 10 s. Proprioception was examined by
testing the sense of position and passive movement. For the passive
straight-leg-raising test, we lifted the affected leg extended at the
knee to a 90u angle unless elevation was limited by pain; this was
followed by an elevation of the leg flexed at the knee. We
considered the test result positive when pain projecting into a
dermatome was reproduced by raising the affected leg a second
time extended at the knee [20]. To test for temporal summation,
the stronger of the two von Frey filaments was applied repetitively
at a rate of 1–2 Hz for 30 s [21]. If this von Frey filament elicited
pain at baseline, the weaker filament was used instead.
Investigators graded a decreased response to stimulation
following standardized guidelines. For example, a reduced
response to punctate tactile stimulation was considered mild if
the patient failed to notice stimulation with the low-strength von
Frey filament but detected the high-strength filament. If pain was
provoked by a test stimulus, we asked the patient to rate the
intensity of this particular pain using an NRS. All tests were
carried out in the affected (painful) body area. We compared the
results with the response to stimulation in an adjacent or
contralateral area that was free of pain or any other sensory
disorder such as numbness or dysesthesia. For diabetic patients
with neuropathic symptoms and signs below the knee, we chose
the thigh as reference. For patients with PHN, we examined the
contralateral dermatome. For patients with LBP, we examined a
reference area in the midline of the back above the painful area
(usually around T12), and if the patient had leg pain, the
corresponding dermatome of the opposite leg.
All investigators involved in the study were experienced
clinicians. Training sessions were held before patients were
recruited to ensure that each investigator was performing the
assessment of pain-related symptoms and signs in the same way
and that the interpretation of patient responses was consistent
between investigators.
Statistical analysis. Groups of patients with similar responses
in the interview and the physical examination were identified by
hierarchical cluster analysis. Using the function DAISY of R
(version 2.0.1; R Foundation for Statistical Computing, Vienna,
Austria; http://www.r-project.org/), we calculated a distance
matrix based on Gower’s general dissimilarity coefficient [22].
Binary variables were treated as asymmetric. We applied Ward’s
method [23] to perform a hierarchical cluster analysis on the
distance matrix. In the resulting dendrogram, we set an arbitrary
separation threshold so that the resulting clusters would not include
fewer than approximately 10% of the total patients.
A classification tree with either a patient’s clinical diagnosis or
assignment to one of the patient clusters as outcome variables was
derived using the RPART function of R. For classification with the
diagnosis as outcome variable, the patients were randomly
partitioned into a training set (two-thirds of the patients) and a
test set (the remaining third), with each diagnosis represented at
the same proportion in both sets as in the overall group of patients.
For classification with the patient clusters as outcome variable, all
patients were used to train the tree with 10-fold cross-validation.
Here, we intended to determine the minimum number of
interview questions and physical tests that allowed correct
assignment of the patients to the clusters. We named this shorter
version of the initial assessment tool Standardized Evaluation of
Pain (StEP).
Part 2. Validation
Participants. In Part 2 of the study, we applied StEP to an
independent group of patients with chronic LBP to validate the
assessment tool for the distinction between radicular and axial
back pain (Figure 1). The patients were recruited through
physician referrals, using the same eligibility criteria as in Part 1
of the study.
Standardized evaluation of pain. StEP consists of a brief
structured interview including six questions and ten standardized
physical tests (see Text S1). To ensure a consistent application of
StEP, we trained the investigators at the beginning of the validation
study and provided them with detailed written instructions on how
to conduct the interview, perform the physical tests, and interpret
and document the findings (see Text S1).
Measures of diagnostic accuracy. We used the clinical
diagnosis as the reference standard to determine the sensitivity and
specificity of StEP and its positive and negative predictive values
Symptoms and Signs Define Pain Subtypes
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for the distinction between radicular and axial back pain. A
patient’s back pain was classified as radicular or axial by an
interdisciplinary team of at least two experienced physicians—
usually a rheumatologist and a neurosurgeon—and a spinal
physiotherapist, who were not involved in the study. Typically, the
physicians and the physiotherapist based their diagnosis on a
detailed history and a comprehensive neurological and
rheumatological examination that included testing for radicular
sensory or motor deficits, reduced tendon reflexes, neurogenic
claudication, and an evaluation of back mobility and muscle
spasm. Further investigations such as electromyography, spinal
magnetic resonance imaging (MRI), or computed tomography,
with or without myelography, were carried out if deemed
necessary. The study investigators who applied StEP were blind
to the clinical classification of back pain and the results of
additional investigations.
We compared StEP with the Douleur Neuropathique en 4 Questions
(DN4) screening tool for neuropathic pain [24]. The DN4 consists
of seven interview questions and three physical tests. Administra-
tion of the DN4 interview alone has been proposed for use as a
self-administered questionnaire in epidemiological surveys [24].
We incorporated all ten DN4 items in the assessment in a double-
blind fashion; neither the patients nor the investigators were able
to differentiate between elements belonging to StEP or the DN4.
Some items such as the question about the presence of burning
pain were common to both assessments. Items specific to the DN4
such as the test for a decreased pricking sensation after application
of a von Frey filament of 5.1 g force were grouped with similar
StEP items to mask their origin. We analyzed the results of both
the complete ten-item version and the seven-item interview part of
the DN4 and compared them with the outcome of StEP.
Spinal imaging. Spinal MRI is a widely used noninvasive
method to assess degenerative changes of the spine and
intervertebral disk pathology leading to nerve root compression.
We analyzed the MR images of those patients who were referred
for the procedure as part of their diagnostic evaluation. The
decision to refer a patient for spinal MRI was made independently
of the study by the attending physicians. MRI of the lumbar spine
was performed with a 1.5-T scanner (Signa, General Electric
Healthcare, Slough, United Kingdom) and a dedicated receive-
only spine coil. The imaging protocol included the following
sequences: sagittal T2-weighted fast spin echo (TR 3200–3800 ms,
TE 95–105 ms, 3 NEX, 5126512 matrix), sagittal T1-weighted
spin echo (TR 400–820 ms, TE 9–22 ms, 3 NEX, 5126512
matrix), and axial T2-weighted fast spin echo (TR 2700–5500 ms,
TE 100–118 ms, 4 NEX, 5126512 matrix). MR images of the
lumbar spine at the L3/L4, L4/L5, and L5/S1 segmental levels
were read by an experienced specialist in neuroradiology who was
Figure 1. Standards for the Reporting of Diagnostic Accuracy (STARD) flowchart for the validation of StEP (Part 2 of the study).
doi:10.1371/journal.pmed.1000047.g001
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blind to the clinical diagnosis and the result of the pain assessment.
Nerve root impairment was graded depending on contact between
intervertebral disks and nerve roots, nerve root deviation, and
compression [25]. The severity of spinal canal and lateral recess
stenoses was rated from 0/3 (none) to 3/3 (marked) [26]. Changes
in the signal intensity of bone marrow along the cartilaginous
endplates were classified according to Modic’s types 1 to 3 [27].
Degenerative disk changes were graded from I (homogenous,
bright white appearance of the disk) to V (collapsed disk space)
[28]. Pathological changes of the facet joints were classified on the
basis of width of the facet joint space, presence of osteophytes,
hypertrophy of the articular processes, subarticular bone erosions,
and subchondral cysts [29].
Assessment of face validity. After completion of the pain
assessment, we asked the patients to evaluate StEP on a
standardized self-administered form. Using an NRS from 1 to 5,
the patients graded the accuracy and comprehensiveness of the
pain assessment, and how difficult it was for them to respond to the
interview questions and comply with the physical tests. The
patients also rated their willingness to repeat the pain assessment
during a future visit.
Sample size and power. Not considering pain intensity
ratings and the question about current pain, the 16 interview
questions and physical tests of StEP contain 45 binary predictors.
For the purpose of calculating statistical power, we constructed a
composite score consisting of a linear combination of these
predictors and estimated the sensitivity and specificity of StEP in
distinguishing between radicular and axial back pain. We generated
a receiver operating characteristic (ROC) curve for the score based
on the results that we obtained in the previous part of our study. The
estimated area under the ROC curve was 0.97. Assuming that the
area under the curve (AUC) in the validation study would be 0.90,
we calculated that a sample size of 65 patients per diagnostic group
would provide 80% power to determine in a two-sided test at the
0.05 significance level whether the AUC is $0.80.
Statistical analysis. We employed the software SAS (version
9.1.3; SAS Institute, Cary, North Carolina, United States) for the
statistical analysis of our validation study. Only complete patient
data sets were included in the analysis.
Using the LOGISTIC procedure of SAS, we performed a
logistic regression analysis to examine the relationship between
StEP items and the clinical diagnosis of radicular and axial LBP.
We fitted a linear logistic regression model for binary response
data by the method of maximum likelihood. Based on the
regression coefficients of StEP items, we created numerical scores
that reflect the size of the contribution of these variables to the
outcome. Potential cutoff values for the total StEP score were
evaluated based on the number of correctly classified patients and
the balance between sensitivity and specificity to identify patients
with radicular LBP. We generated an ROC curve for the fitted
model and calculated its AUC using the trapezoid rule. An ROC
curve is a graphical representation of the test results with the AUC
being measured in a range of 0 to 1. Values close to 1 indicate a
higher power of discrimination between a positive (radicular LBP)
and a negative (axial LBP) test outcome. We also constructed
ROC curves for the ten-item and seven-item versions of the DN4
screening tool and for the radiological assessment of nerve root
impairment by spinal MRI. To compare the AUCs of ROC
curves, we generated an estimated covariance matrix based on a
nonparametric approach using the theory on generalized U-
statistics [30].
Sensitivity, specificity, and positive and negative predictive
values for identifying patients with radicular back pain and the
corresponding two-sided 95% confidence intervals (CIs) are
provided for each diagnostic method. Areas under the ROC
curves are given as mean6standard error.
Results
We assessed 219 patients in Part 1 of the study and 155 patients
in Part 2 for eligibility. Thirty-two patients in Part 1 and 11
patients in the Part 2 were excluded because the duration or
average global intensity of their pain did not meet the inclusion
criteria, or because they suffered from other painful disorders, or
neurological or psychiatric diseases that would have compromised
the evaluation of their pain. Another six patients with LBP were
excluded from the validation study, because there was no
unanimous decision between the attending physicians on the
clinical classification of their pain as radicular or axial. One patient
in the validation study was lost to follow-up because his records
were incomplete. Table 1 lists the clinical characteristics of the
patients included in the study.
Part 1. Development of a Standardized Evaluation of Pain
Symptoms and signs define distinct patient
subgroups. We used a hierarchical cluster analysis to examine
associations between pain-related symptoms and signs in the 187
patients that were included in Part 1 of our study and identified
eight subgroups of patients (patient clusters) with distinct
constellations of symptoms and signs (pain subtypes) (Figure 2A).
The clusters C1 through C6 included the vast majority of patients
with neuropathic pain, whereas patients with non-neuropathic
(axial) LBP formed the clusters C7 and C8 (Figure 2B), indicating a
clear difference between association patterns of symptoms and signs
in patients with neuropathic and non-neuropathic pain. However,
some symptoms and signs were common among patients with axial
LBP and patients with radicular LBP, particularly those 23 patients
with radicular LBP in clusters C5 and C6 (Figure 2). These patients
exhibited, for example, a combination of deep pain, pain evoked by
activity, and, in the physical examination, increased pressure
sensitivity of paraspinal deep tissues that was also seen in patients
with axial LBP. Patients with radicular LBP in C5 and C6 differed
from those in C4 mainly because they had fewer sensory deficits.
Figure 3 shows the symptoms and signs that characterized the
different patient clusters.
Patients with DN, PHN, and radicular LBP were distributed
across clusters C1 through C6, demonstrating that the symptoms
and signs of neuropathic pain that are produced by these diseases
overlap considerably (Figure 2B). Only the pain subtype
represented in cluster C1 can be considered disease-specific.
Twenty-four of the 26 patients in this cluster had DN (Figure 2B).
Patients in this cluster reported predominantly deep pain, tingling
dysesthesia, and numb skin areas. Their ability to discriminate
tactile and thermal stimuli was reduced in all sensory tests. The
physical examination further revealed the presence of pinprick
hyperalgesia, abnormal temporal summation of repetitive stimuli,
and trophic changes (Figure 3). On the other hand, we found an
equal number of patients with DN in clusters C2 (14 patients) and
C4 (ten patients; Figure 2B), indicating that diagnosis of a disease
does not predict a particular pain subtype defined by symptoms
and signs.
The physical examination was essential for the distinction of
pain subtypes. A cluster analysis based only on physical test results
separated clearly between patients with neuropathic and non-
neuropathic pain (Figure 4A). The results of the physical
examination defined a large cluster of 129 patients, which
included only six patients with axial LBP. This ‘‘neuropathic
cluster’’ further split into two subgroups, 104 patients with
Symptoms and Signs Define Pain Subtypes
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decreased detection of warm or cold temperature and 25 patients
with normal responses to warm and cold stimulation (Figure 4A).
The ‘‘non-neuropathic cluster’’ of 58 patients included 51 patients
with axial LBP; six patients in this cluster had radicular LBP and
one patient DN. Patients in the ‘‘non-neuropathic cluster’’ showed
normal responses to stimulation with von Frey filaments, light
pressure, brush movement, and pinprick but exhibited increased
sensitivity to firm pressure.
In contrast, differentiation of patient subgroups based only on
symptoms described in the interview was weak and did not
discriminate between patients with neuropathic and non-neuro-
pathic pain (Figure 4B). The most prominent split here separated
131 patients with predominantly ongoing pain or dysesthesia from
a group comprising 56 patients with intermittent episodes of pain
or dysesthesia (Figure 4B). Subgroups within these major clusters
differed by descriptions of deep versus superficial pain, the sensory
quality of the pain, or numb skin areas. In the large cluster of 131
patients with ongoing symptoms, 97 patients had DN, PHN, or
radicular LBP, and 34 patients had axial LBP; in the group of 56
patients with intermittent episodes of pain or dysesthesia, 33
patients had neuropathic pain, and 23 patients had axial LBP.
Patients with axial LBP described a deep pain of predominantly
aching or dull quality, but similar pain descriptions were recorded
from patients with radicular LBP or DN (Figure 3).
Key characteristics of pain subtypes. Pinprick was the
most sensitive (95%; 95% CI 89%–97%) and most specific (93%;
95% CI 83%–98%) single test to distinguish between neuropathic
and non-neuropathic pain. The response to pinprick was
decreased or hyperalgesic in 123 of 130 patients with DN, PHN,
or radicular LBP, as opposed to four out of 57 patients with axial
LBP. The pinprick test must evaluate a decrease in the detection
threshold; pinprick hyperalgesia alone is not a specific indicator of
neuropathic pain [31–33]. Among patients clinically diagnosed
with neuropathic pain, a positive straight-leg-raising test indicated
radicular LBP with high specificity (100%). A decreased response
to vibration differentiated between painful DN and PHN with a
specificity of 98% and a sensitivity of 82%. These three parameters
(response to pinprick, straight-leg-raising test, and response to
vibration) combined had an empirical positive predictive value of
93% (95% CI 68%–99%) for painful DN, 40% (95% CI 19%–
63%) for PHN, 100% (95% CI 59%–100%) for radicular LBP,
and 85% (95% CI 63%–96%) for axial LBP (Figure 5A). The
Table 1. Patient characteristics.
Characteristic Study Part 1: Development of StEP Study Part 2: Validation
DN PHN Radicular LBP
Neuropathic
Pain (Total) Axial LBP Radicular LBP Axial LBP
Total number 50 23 57 130 57 75 62
Age, median (range), y 55 (38–71) 67 (45–92) 50 (20–85) 55 (20–92) 46 (19–77) 45 (20–82) 55 (24–78)
Women 27 (54) 11 (48) 28 (49) 66 (51) 35 (61) 41 (55) 35 (56)
Men 23 (46) 12 (52) 29 (51) 64 (49) 22 (39) 34 (45) 27 (44)
Pain duration, y, median (range) 4 (0.42–15) 2 (0.25–34) 4 (0.33–29) 4 (0.25–34) 5 (0.33–39) 1 (0.25–34) 5 (0.33–46)
Global pain intensity, NRS, median (range)a 5 (0–10) 4 (0–10) 5 (0–10) 5 (0–10) 5 (0–8) 8 (6–10) 7 (6–10)
Analgesic treatment (drugs)
Antidepressants 4 (8) 5 (22) 7 (12) 16 (12) 4 (7) 11 (15) 13 (21)
Anticonvulsants 16 (32) 8 (35) 14 (25) 38 (29) 9 (16) 10 (13) 5 (8)
NSAIDs, acetaminophen 28 (56) 10 (43) 39 (68) 77 (59) 47 (82) 54 (72) 49 (79)
Muscle relaxants 1 (2) 0 (0) 16 (28) 17 (13) 11 (19) 1 (1) 0 (0)
Benzodiazepines 0 (0) 0 (0) 4 (7) 4 (3) 4 (7) 6 (8) 4 (6)
Opioids 12 (24) 8 (35) 28 (49) 48 (37) 26 (46) 45 (60) 41 (66)
Local anestheticsb 0 (0) 6 (26) 2 (4) 8 (6) 4 (7) 1 (1) 1 (2)
Glucocorticoidsb 1 (2) 1 (4) 15 (26) 17 (13) 10 (18) 3 (4) 2 (3)
Otherc 0 (0) 0 (0) 2 (4) 2(2) 1 (2) 1 (1) 4 (6)
Analgesic treatment (other)
Physical therapy 7 (14) 1 (4) 32 (56) 40 (31) 27 (47) 7 (9) 12 (19)
TENS, SCS 1 (2) 0 (0) 5 (9) 6 (5) 2 (4) 3 (4) 7 (11)
Chiropractic 0 (0) 1 (4) 11 (19) 12 (9) 6 (11) 0 (0) 0 (0)
Acupuncture 7 (14) 4 (17) 6 (11) 17 (13) 6 (11) 1 (1) 0 (0)
Otherd 1 (2) 0 (0) 4 (7) 5 (4) 1 (2) 1 (1) 3 (5)
No treatment 9 (18) 2 (9) 2 (4) 13 (10) 2 (4) 8 (11) 2 (3)
Data are presented as number (%) unless otherwise indicated.
aAs reported on the day of the assessment, prior to the examination. Some patients with predominantly intermittent pain episodes were free of pain at this time
(NRS = 0).
bTopical application or injection.
cMexiletine (1), zopiclone (1), glucosamine (1), quinine (1), and botulinum toxin injections (3).
dLumbar support (2), muscle relaxation (1), massage (1), meditation (2), yoga (2), hypnosis (1), and magnets (1).
NRS, numerical rating scale; NSAIDs, nonsteroidal anti-inflammatory drugs; SCS, spinal cord stimulation; TENS, transcutaneous electrical nerve stimulation.
doi:10.1371/journal.pmed.1000047.t001
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corresponding negative predictive values were 93% (95% CI
82%–98%), 100% (95% CI 91%–100%), 78% (95% CI 65%–
88%), and 97% (95% CI 87%–99%).
Elements of the physical examination were also dominant
among those variables that were identified in a classification tree
analysis as key determinants of the assignment of patients into
clusters: response to pinprick and cold temperature, presence of
trophic skin changes, and performance in the proprioceptive tests
(Figure 5B). Pain quality and the quality of dysesthesia were
important for the distinction between the clusters C2, C3, and C4,
and for the differentiation between the clusters C7 and C8, which
comprised most of the patients with axial LBP (Figure 5B). Based
on the responses to these six most discriminatory elements of the
assessment alone, the probability of correct assignment of patients
into clusters was 73% (95% CI 66%–79%), missing only the
smallest cluster, C5, which consisted of nine patients with radicular
LBP and two patients with axial LBP (Figure 2B).
Of 112 patients who described numb skin areas in the interview,
89 had a decreased response to at least one tactile or thermal test
stimulus in the physical examination; 73 patients had decreased
responses in both tactile and thermal tests. However, the physical
examination revealed sensory deficits with higher sensitivity (in
130 patients) than the interview. In some patients skin patches with
sensory loss were adjacent to areas of stimulus-evoked pain, a
mixture of negative and positive signs that is a well-known feature
of neuropathic pain [21,34].
Standardized evaluation of pain. Based on the symptoms
and signs that differentiated between the eight patient subgroups,
we created a short form of the initial pain assessment tool that we
named Standardized Evaluation of Pain (StEP). StEP comprises
six interview questions and ten physical tests (see Text S1) that
captured the key characteristics of the neuropathic pain subtypes
and those features that distinguished between neuropathic and
non-neuropathic pain in our patients. The application of StEP
required 10–15 min, as opposed to the comprehensive assessment
that included 16 interview questions and 23 tests and lasted 60–
90 min.
Part 2. Validation
Our findings indicated two possible applications for StEP, a
differentiation of pain subtypes and the dichotomous distinction
between neuropathic and non-neuropathic pain. Both applications
are clinically valuable, yet reference standards for pain subtypes do
not exist, so we decided to validate StEP for the separation
between LBP with (radicular) and without (axial) involvement of
the nervous system. This distinction, which has immediate
consequences for therapeutic decisions [35,36], can be challenging
and often necessitates costly additional investigations. The
reference standard for the validation was an independent clinical
diagnosis of radicular or axial LBP achieved by an interdisciplin-
ary team of at least two attending physicians and a spinal
physiotherapist (Figure 1). Their diagnosis was typically founded
on a comprehensive interview and physical examination of the
patient, along with the results of additional investigations including
spinal imaging.
Distinction between radicular and axial back pain. We
used a logistic regression analysis to determine the size of the
contribution of interview questions and physical tests included in
StEP to the separation between radicular and axial LBP. The
results confirmed our initial observation that physical tests have
Figure 2. Hierarchical cluster analysis of patient subgroups defined by constellations of pain-related symptoms and signs. (A)
Individual patients are symbolized by short vertical lines at the bottom of the dendrogram. Horizontal lines indicate similarities between the patients’
pain, whereas upper vertical lines represent differences between pain-related signs or symptoms. At the indicated separation threshold (arrow), we
identified eight subgroups of patients (clusters C1 to C8) with distinct constellations of pain-related symptoms and signs (pain subtypes). (B) Patients
with DN, PHN, and radicular LBP were distributed across the clusters C1 to C6, whereas patients with axial LBP almost exclusively formed the clusters
C7 and C8.
doi:10.1371/journal.pmed.1000047.g002
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more discriminatory power than interview items. A positive
straight-leg-raising test and abnormal responses to cold stimulation
and pinprick were key indicators of radicular LBP (Table 2).
Decreased response to cold stimulation or pinprick was more
important for the diagnosis of radicular LBP than cold allodynia or
pinprick hyperalgesia, respectively. For example, 56 of the 75
patients with radicular LBP showed a reduced response to
pinprick, compared to only 11 of the 62 patients with axial LBP,
whereas 21 patients in either diagnostic group reported pinprick
hyperalgesia. A burning pain quality and dynamic tactile allodynia
did not constitute characteristic features of radicular LBP (Table 2),
unlike peripheral neuropathic pain in other conditions [32,37].
Based on the regression coefficients of StEP variables, we
implemented a scoring system that indicates in an individual
patient whether LBP is more likely to be radicular than axial (see
Text S2). A cutoff value of 4 for the total score yielded 92%
sensitivity (95% CI 83%–97%) and 97% specificity (95% CI 89%–
100%), correctly identified 129 clinically diagnosed patients (94%),
and had high positive and negative predictive values for the
diagnosis of radicular LBP (Table 3). An ROC curve based on the
sensitivity and specificity of StEP using this scoring system had an
AUC of 0.9860.01 (Figure 6). When the straight-leg-raising test
was excluded from the analysis, the diagnostic accuracy of StEP
was still high, as indicated by an area under the ROC curve of
0.8560.03 (Figure 6).
We compared StEP with a screening tool for neuropathic pain,
the DN4 [24], which consists of seven interview questions and
three physical tests. The physical tests assess whether sensibility to
a brush touching the skin and the pricking sensation elicited by a
von Frey filament are decreased, and whether movement of a
brush over the skin produces a painful response. A short version of
the DN4 comprises only the seven interview items [24]. The
sensitivity of the ten-item version of the DN4 in our study was 61%
(95% CI 49%–72%) and its specificity 73% (95% CI 60%–83%).
Ninety-one patients (66%) were accurately identified as having
radicular or axial LBP (Table 4). The seven interview items of the
DN4 provided an accurate diagnosis in 86 patients (63%);
sensitivity and specificity of the seven-item version of the DN4
were 68% (95% CI 56%–78%) and 56% (95% CI 43%–69)
(Table 4). The areas under the ROC curves6standard errors for
the ten-item and the seven-item versions of the DN4 were
0.7160.04 and 0.6760.05, respectively (see Figure S1), signifi-
cantly lower than the area under the ROC curve for StEP
independent of whether the straight-leg-raising test was included
in the analysis of StEP’s diagnostic accuracy (p,0.001 for either
version of the DN4) or not (p,0.01 for the ten-item version of the
DN4, and p,0.001 for the seven-item version).
A large number of patients with radicular and axial LBP were
included in Part 1 of the study. For an independent evaluation of
the logistic regression model that we used to derive the scoring
Figure 3. Association patterns of pain-related symptoms and signs. Circles indicate the presence of symptoms and signs, with empty circles
denoting a sensory deficit. The diameter of the circles reflects the relative frequency of each symptom or sign in a patient cluster independent of the
intensity of pain associated with the symptom or sign, or the severity of sensory loss. Closely related items are grouped, for example the responses to
stimulation with the von Frey filaments of 2.0-g and 26.0-g strength.
doi:10.1371/journal.pmed.1000047.g003
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system for StEP, we applied the scores retrospectively to equivalent
items of the initial pain assessment tool and determined how back
pain would have been classified in these patients. We found that
89% of the patients would have been diagnosed correctly as
having radicular or axial LBP, and that the sensitivity and
specificity in discriminating between the two groups of patients
would have been 79% (95% CI 63%–90%) and 98% (95% CI
89%–100%), respectively. These numbers underline the diagnostic
utility of the scoring system. Its reduced sensitivity when applied
retrospectively is likely explained by differences between StEP and
the assessment tool that we employed to evaluate pain-related
symptoms and signs in Part 1 of our study. This initial tool
contained more interview questions and physical tests, and there
were also minor differences in the wording of questions and test
instructions.
Comparison with spinal MRI. Fifty-one patients with
radicular LBP and 22 patients with axial LBP were examined by
spinal MRI. Table S2 lists the radiological findings for the two
patient groups. We considered nerve root impairment by a
herniated intervertebral disk [25] and stenosis of either the spinal
canal or a lateral recess indicators of radicular pain [26]. MRI of
the lumbar spine had 96% sensitivity (95% CI 87%–100%) but
only 18% specificity (95% CI 5%–40%) in identifying patients
with radicular LBP when any contact of disk material with a nerve
root and a spinal canal or lateral recess stenosis of $1/3 were
regarded indicators of nerve root involvement. The specificity
increased to 41% (95% CI 21%–64%) when higher cutoff scores
(deviation of a nerve root and $2/3 stenosis of the spinal canal or
a lateral recess) were applied (see Figure S2). With these stricter
criteria, the sensitivity of the MRI was still high with 86% (95% CI
74%–94%), but the corresponding ROC curve had an AUC of
only 0.6960.06 (Table 4). In the subset of patients who were
examined by MRI, StEP distinguished between radicular and
axial LBP with a sensitivity of 90% (95% CI 79%–97%) and a
specificity of 95% (95% CI 77%–100%), providing substantially
higher diagnostic accuracy than MRI (Table 4).
The severity of vertebral endplate abnormalities, intervertebral
disk degeneration, and facet joint arthrosis was similar in patients
with radicular LBP and patients with axial LBP (see Table S2).
Subtypes of low back pain. Although the primary aim of
the validation was to determine the sensitivity and specificity of
StEP in distinguishing radicular from axial LBP, we sought to
Figure 4. Physical examination, rather than symptom exploration, is crucial for the differentiation between patient subgroups. (A) A
hierarchical cluster analysis based solely on the results of physical tests. (B) The same analysis including only pain-related symptoms reported in the
interview.
doi:10.1371/journal.pmed.1000047.g004
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identify patients with those subtypes of LBP that we had
characterized in Part 1 of our study. Based on the criteria
specified in the previous classification tree analysis (Figure 5B), we
found 12 patients with radicular LBP who exhibited symptoms
and signs analogous to those of patients in previous cluster C4,
most prominently sensory deficits in response to tactile and
thermal stimuli. Symptoms and signs in another 44 patients with
radicular LBP matched the pain characteristics of patients in
previous cluster C6 (Figure 7). And in 11 and 21 of the patients
with axial LBP we found association patterns of symptoms and
signs analogous to those observed in the previous clusters C7 and
C8, respectively (Figure 7). LBP in these two patient subgroups
differed mainly by its sensory quality, for example the presence of
‘‘painful pins and needles.’’ Considering the limited discriminatory
power of pain qualities, the subtypes of axial LBP that we
identified in Part 1 of our study might not be as robust as those of
radicular LBP. Overfitting of the classification tree to these
symptoms would explain why only half of the patients with axial
LBP in Part 2 of the study matched the classification criteria for
clusters C7 or C8.
Face validity of StEP. StEP was evaluated by 134 patients.
These patients regarded StEP as a suitable and appropriate tool
for the assessment of their pain. StEP’s comprehensiveness was
rated 5 (median; lower quartile, Q1= 4; upper quartile, Q3= 5) on
a numerical scale of 1 (many important aspects of the pain were
missed) to 5 (very good representation of the pain). The ease of
answering the interview questions was rated 5 (Q1= 4; Q3= 5) on
a scale of 1 (very difficult) to 5 (very easy). The ease of compliance
Figure 5. Identification of discriminatory pain assessment items. (A) Using a classification tree analysis, we determined symptoms and signs
that characterized the pain in patients with DN, PHN, radicular LBP, and axial LBP. We identified an abnormal response to pinprick (either decreased
response or hyperalgesia) as the best indicator of neuropathic pain. Abnormal responses to cold or warm stimuli and to blunt pressure further
supported the distinction between neuropathic pain and non-neuropathic (axial) LBP. Among patients with neuropathic pain, a positive straight-leg-
raising sign was closely associated with radicular LBP, and a deficit in the detection of vibration was the best marker of DN. aLBP, axial low back pain;
rLBP, radicular low back pain. (B) In a separate analysis, we identified those pain assessment items that contributed to the differentiation of pain
subtypes. Responses to physical tests dominated among the key characteristics of pain subtypes responsible for the allocation of patients into
clusters C1 to C8. Pain assessment items in (A) and (B) are listed according to their contribution to the differentiation of painful conditions and pain
subtypes, respectively. The most discriminatory items are shown on top and in bold font.
doi:10.1371/journal.pmed.1000047.g005
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with the physical examination also scored as 5 (Q1= 5; Q3= 5).
The willingness to complete the assessment again as a measure of
change after treatment was 5 (Q1= 5; Q3= 5) on an NRS from 1
to 5, indicating high acceptance of the assessment tool. We used a
two-tailed Wilcoxon rank sum test to compare how patients with
radicular LBP and those with axial LBP evaluated StEP and found
no significant difference in their assessment of StEP’s
comprehensiveness (p=0.96), the ease of answering the interview
questions (p=0.69), or ease of compliance with the physical tests
(p=0.56). Patients in both groups indicated that they would be
willing to complete StEP again (p=0.17).
Discussion
Chronic pain is a complex experience comprising the sensation
of pain itself as well as autonomic responses, psychological
reactions, and social consequences [1]. Here we explored
commonalities and differences in the sensory components of
peripheral neuropathic and non-neuropathic pain. Using a
structured interview and a standardized physical examination,
we identified and characterized subtypes of chronic pain
independent of etiological disease categories. We did not attempt
to measure disturbances in affect, behavior, or quality of life, for
which other assessment tools are available [1]
We found that relatively few symptoms and signs can
differentiate a set of distinct neuropathic pain subtypes, and that
these are not defined by the condition causing the pain. Somewhat
surprisingly for a sensory disorder, the physical examination was
more sensitive than the exploration of symptoms for the distinction
between subtypes of neuropathic pain and the separation between
neuropathic and non-neuropathic pain. The quality of the pain
was certainly less important than suggested by previous methods
that relied exclusively on a patient interview. But the most
discriminatory tests, as identified by a classification tree analysis,
were generally familiar and not unexpected, such as pinprick for
the detection of a sensory deficit or hyperalgesia [31,33].
Based on their contribution to the identification of pain
subtypes, we created a tool for a standardized assessment of pain
that consists of six interview questions and ten physical tests, which
are easily applicable in a bedside examination. We hypothesize
that pain subtypes characterized by distinct patterns of these pain-
related symptoms and signs indicate active biological mechanisms.
Spontaneous burning pain, for example, may be driven by ectopic
discharges in heat-sensitive nociceptor neurons, whereas pain
evoked by brush stroke (dynamic tactile allodynia) is more likely to
result from an increase in the excitability of dorsal horn neurons
[9,11]. Special investigations including the quantification of
sensory fiber loss in skin biopsies [38], electrophysiological
examinations of nociceptive pathways [39], and functional brain
imaging [40] are critical for the elucidation of the neurobiology of
pain in humans, but they are not suitable for routine clinical
testing. The requirement of technical equipment, special expertise,
and a substantial expenditure in time limit the use of quantitative
sensory testing to evaluate somatosensory function to research
studies involving small patient samples [41]. As a consequence, no
major clinical trial to date has systematically examined the features
of neuropathic pain and, more specifically, their relationship with
treatment response or capacity to predict the response.
Patients with neuropathic pain are usually classified based on
disease diagnosis. However, we did not find a unique correlation of
neuropathic pain-related symptoms and signs with disease except
for one pain subtype associated with a subgroup of patients with
DN. Disease itself does not predict the occurrence or natural
course of neuropathic pain, nor do the etiological factors and
Table 2. StEP scores for the distinction between radicular and
axial LBP.
StEP Variable Score
Radicular pain in the straight-leg-raising test 7
Abnormal response to cold temperature (decrease or allodynia) 3
Abnormal response to pinprick (decrease or hyperalgesia) 2
Abnormal response to blunt pressure (decrease or evoked pain) 1
Decreased response to vibration 1
Dysesthesia (any) 1
Temporal summation 21
Burning or cold quality of the pain 21
Abnormal response to brush movement (decrease or allodynia) 22
Ongoing pain 22
Skin changes (any) 23
Scores reflect the regression coefficients of grouped StEP items; for example, a
score of 2 was given when the response to pinprick was decreased or when
pinprick evoked a hyperalgesic response. StEP items with a regression
coefficient of 0 (zero) are not listed. A higher score is indicative of radicular LBP
(see Table 3).
doi:10.1371/journal.pmed.1000047.t002
Table 3. Accuracy of StEP in identifying patients with radicular LBP at different cutoff values of the total score.
StEP Cutoff
Score Sensitivity Specificity
Correctly Diagnosed
Patients
Positive Predictive
Value
Negative Predictive
Value
6 81 (71–89) 100 (94–100) 123 (90) 100 (94–100) 82 (71–90)
5 88 (78–94) 97 (89–100) 126 (92) 97 (90–100) 87 (77–94)
4 92 (83–97) 97 (89–100) 129 (94) 97 (90–100) 91 (81–97)
3 93 (85–98) 94 (84–98) 128 (93) 95 (87–99) 92 (82–97)
2 96 (89–99) 82 (70–91) 123 (90) 87 (78–93) 94 (85–99)
1 97 (91–100) 69 (56–80) 116 (85) 79 (70–87) 96 (85–99)
0 99 (93–100) 52 (39–65) 106 (77) 71 (61–80) 97 (84–100)
Correctly diagnosed patients are given as number (%). All other values represent % (95% CI).
doi:10.1371/journal.pmed.1000047.t003
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pathological changes that define a neurological disease necessarily
correlate with mechanisms responsible for the manifestation of
spontaneous pain, hyperalgesia, or allodynia, all common features
of neuropathic pain [15,37]. Different pain mechanisms may
operate in patients with the same disease, the same pain
mechanisms can be present in patients with different diseases,
and the relative contribution of particular mechanisms to the pain
in individual patients may change over time [5]. In addition,
changes in the nervous system can become autonomous and
persist long after the primary disease has disappeared, for example
in postherpetic neuralgia.
We show that a standardized evaluation of pain-related
symptoms and signs helps separate patients with neuropathic pain
including radicular LBP from those with non-neuropathic (axial)
back pain. Distinguishing between radicular and axial LBP is often
difficult: nerve root involvement may manifest with a minor
sensory or motor deficit, and patients with LBP originating in the
facet joints or other structures of the spine may experience pain
lateral to the midline, which can be confused with radicular pain.
In addition, degenerative changes of the spine are likely to
contribute also to back pain in patients with nerve root
involvement [8,35]. However, the differentiation between radic-
ular and axial LBP is clinically important and has direct impact on
therapeutic decisions: anticonvulsants and antidepressants are
adjuvant pharmacological treatment options in neuropathic back
pain [42], and patients with persistent radicular pain or
neurological deficits benefit from surgical intervention [36].
We validated StEP for its ability to distinguish radicular from
axial LBP and found that StEP identifies patients with radicular
LBP with high diagnostic accuracy. Based on the results of our
validation study, we propose a scoring system that can be
implemented in the analysis of StEP to detect radicular back pain.
Table 4. Diagnostic accuracy of StEP for the identification of radicular LBP compared to the DN4 screening tool for neuropathic
pain and spinal MRI.
Measure of Accuracy
StEP
(All Patients)
DN4, Ten
Items
DN4, Seven
Items
StEP (Patients
with MRI) Spinal MRIa
AUC, mean6standard error 0.9860.01 0.7160.04b 0.6760.05b 0.9760.02 0.6960.07b
Sensitivity 92 (83–97) 61 (49–72) 68 (56–78) 90 (79–97) 86 (74–94)
Specificity 97 (89–100) 73 (60–83) 56 (43–69) 95 (77–100) 41 (21–64)
Correctly diagnosed patients, number (%) 129 (94) 91 (66) 86 (63) 67 (92)c 53 (73)c
Positive predictive value 97 (90–100) 73 (60–83) 65 (54–76) 98 (89–100) 77 (64–87)
Negative predictive value 91 (81–97) 61 (49–72) 59 (46–72) 81 (61–93) 56 (30–80)
Values represent % (95% CI) unless otherwise noted.
aUsing deviation of a nerve root caused by disk herniation and moderate stenosis ($2/3) of the spinal canal or a lateral recess as cutoff values.
bp,0.001, when compared to the area under the ROC curve for StEP.
cThe spinal MR images of 73 patients were analyzed.
doi:10.1371/journal.pmed.1000047.t004
Figure 6. ROC curves for the distinction between radicular and axial LBP based on StEP.
doi:10.1371/journal.pmed.1000047.g006
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The most discriminatory indicators for radicular pain were a
positive straight-leg-raising sign, a deficit in the detection of cold,
and a reduced response to pinprick. This is not too surprising: the
straight-leg-raising test is routinely performed in the examination of
patients with back pain [8], and demonstration of a sensory deficit in
the innervation territory of a lesioned nervous structure is a
diagnostic criterion of neuropathic pain [10]. Standardized
application and interpretation substantially improve the diagnostic
utility of both the straight-leg-raising test and the assessment of
sensory function, whereas evaluation of sensory abnormalities
without defined stimuli increases the variability of outcomes [14–
16]. Radicular pain in a positive straight-leg-raising test is probably
caused by traction on an impinged nerve root and may be enhanced
by local edema, inflammation of the affected nerve root, or venous
blood flow obstruction [20]. Differences in the procedure and the
interpretation of the straight-leg-raising test are likely to account for
conflicting conclusions on its diagnostic utility in clinical practice
[20,43]. Evaluations of the test further depend on the reference
standard used. Some studies compared its sensitivity and specificity
to a radiological assessment of nerve root impairment in spinal MRI
[44]. The gold standard for the distinction between radicular and
axial LBP should, however, be a conclusive clinical diagnosis that
draws on several sources of information including if applicable—
MRI or computed tomography, electrophysiological investigations,
and surgical records [10,37].
The DN4 screening tool for neuropathic pain was developed in
a study not involving patients with radicular LBP [24]. The
complete version of the DN4 contains three physical tests, for a
reduced sensibility to a brush touching the skin, a decreased
pricking sensation elicited by a von Frey filament, and a painful
response to brush movement. However, like other screening tools
for neuropathic pain [45–47], the DN4 relies largely on a
structured exploration of the patient’s history. Pain assessment
tools that comprise solely interview questions or combine a
questionnaire and self-administered tests [48] have advantages for
use in epidemiological studies but, as our results suggest, they may
Figure 7. Association patterns of symptoms and signs in patients with chronic LBP in Part 2 of the study. Subgroups of patients with
radicular and axial LBP were identified based on those symptoms and signs that characterized the patient clusters C4, C6, C7, and C8 in Part 1 of the
study (compare Figure 5B).
doi:10.1371/journal.pmed.1000047.g007
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lack sensitivity and specificity when applied in clinical practice.
Generally these questionnaires are constructed as a short list of
items that have been selected a priori based on clinical experience,
with the assumption that these items will constitute useful
measures for the assessment of pain. Our approach was quite
different. We analyzed a comprehensive range of pain-related
symptoms and signs without any presumption of their clinical
importance. We found that physical tests are more useful for
identifying patients with neuropathic back pain than interview
questions, and that only a standardized assessment of both
symptoms and signs allows a differentiation between subtypes of
pain.
Further studies are needed to determine the accuracy of StEP
for the distinction of neuropathic and non-neuropathic pain in
conditions other than LBP. The discriminatory value of single
variables will certainly vary depending on each condition.
However, we believe that the interview questions and physical
tests included in StEP will be sufficient, because StEP was still
highly sensitive and specific in discriminating between radicular
and axial LBP after excluding the straight-leg-raising sign, which
has utility only for the diagnosis of radicular LBP. Future studies
will also have to address important issues such as test-retest and
intra- and inter-rater reliability, which we did not investigate here.
Whether successful analgesic treatment modifies the presence or
intensity of specific painful symptoms or signsremains to be
investigated, but the reliability of StEP is likely to be affected by
the response to treatment. It is therefore possible that we would
have observed different constellations of symptoms and signs in
untreated patients, of whom only a few were included in the
present study (Table 1).
Spinal imaging is recommended for the evaluation of patients
who have LBP that persists beyond 4 weeks, exhibit severe or
progressive neurologic deficits, or are suspected of having a serious
underlying condition such as vertebral infection or cancer [35].
MRI is the preferred technique, because it depicts intervertebral
disks, nerve roots, and the spinal canal better than computed
tomography and does not expose the patient to ionizing radiation.
However, the specificity of MRI in the identification of nerve root
involvement is reduced by the prevalence of degenerative changes
of the spine in asymptomatic individuals [49]. Studies comparing
clinical and radiological findings demonstrated that the degree of
disk displacement in MRI correlates with outcome in the straight-
leg-raising test, but not or only poorly with the severity of radicular
pain or motor or sensory deficits [50]. We found that spinal MRI
is a sensitive diagnostic tool for the identification of radicular LBP,
but its specificity was lower than that of two clinical methods, StEP
and DN4, despite the application of standardized evaluation
criteria. Higher cutoff values for the radiological assessment of
nerve root impairment improved the specificity of MRI to some
extent, but any findings will always need to be evaluated in their
clinical context [35].
We demonstrate that a standardized assessment of pain-
related symptoms and signs provides a simple diagnostic
procedure for the distinction between radicular and axial LBP.
This distinction is crucial because back pain is a diagnostic label
for a heterogeneous group of patients and it is often difficult to
decide which patients will benefit from treatment strategies that
target neuropathic pain. However, the potential therapeutic
implications of a standardized method to identify pain subtypes
go beyond the dichotomous separation between neuropathic and
non-neuropathic pain. First-line medications recommended for
neuropathic pain include anticonvulsants, tricyclic antidepres-
sants, and opioids [51–53]; they are effective only in a
proportion of the patients and reduce pain by $50% in only
25%–50% of the cases [53,54]. As predictors of treatment
response or failure are unknown, therapeutic decisions are
largely based on empirical criteria and the presence of
comorbidities [51–53]. Differences between underlying pain
mechanisms are one possible explanation for the variability of
treatment response among patients with chronic pain [55].
Classifying patients according to subtypes of pain offers the
possibility of testing if treatment response correlates with the
association patterns of symptoms and signs that define the
subtypes [55,56]. We hypothesize that these patterns reflect pain
mechanisms and, consequently, constitute predictors of treat-
ment efficacy.
Supporting Information
Figure S1 ROC curves reflecting the sensitivity and specificity of
the DN4 screening tool for neuropathic pain in distinguishing
radicular and axial LBP.
Found at: doi:10.1371/journal.pmed.1000047.s001 (0.52 MB
EPS)
Figure S2 Spinal MRI in patients with LBP. (A) An axial T2-
weighted fast spin echo image through the vertebrae L5 and S1
shows a central disk protrusion (arrow) compressing the left S1
nerve root (arrowhead). (B) Marked stenosis (3/3) of the right
lateral recess in an axial T2-weighted fast spin echo image through
the facet joints of the L4 and L5 vertebrae. (C) An axial T2-
weighted fast spin echo image through the L4 and L5 vertebrae
indicates bilateral severe (grade 3) arthrosis of the facet joints.
Found at: doi:10.1371/journal.pmed.1000047.s002 (1.00 MB
EPS)
Table S1 Structure of the initial pain assessment that was used
to develop StEP.
Found at: doi:10.1371/journal.pmed.1000047.s003 (0.07 MB
DOC)
Table S2 Radiological assessment of nerve root involvement and
degenerative changes of spinal structures.
Found at: doi:10.1371/journal.pmed.1000047.s004 (0.07 MB
DOC)
Text S1 Standardized evaluation of pain (StEP).
Found at: doi:10.1371/journal.pmed.1000047.s005 (0.10 MB
PDF)
Text S2 StEP score sheet for the distinction between radicular
and axial low back pain.
Found at: doi:10.1371/journal.pmed.1000047.s006 (0.07 MB
PDF)
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Editors’ Summary
Background. Pain, although unpleasant, is essential for
survival. Whenever the body is damaged, nerve cells detecting
the injury send an electrical message via the spinal cord to the
brain and, as a result, action is taken to prevent further
damage. Usually pain is short-lived, but sometimes it continues
for weeks, months, or years. Long-lasting (chronic) pain can be
caused by an ongoing, often inflammatory condition (for
example, arthritis) or by damage to the nervous system itself—
experts call this ‘‘neuropathic’’ pain. Damage to the brain or
spinal cord causes central neuropathic pain; damage to the
nerves that convey information from distant parts of the body
to the spinal cord causes peripheral neuropathic pain. One
example of peripheral neuropathic pain is ‘‘radicular’’ low back
pain (also called sciatica). This is pain that radiates from the
back into the legs. By contrast, axial back pain (the most
common type of low back pain) is confined to the lower back
and is non-neuropathic.
Why Was This Study Done? Chronic pain is very
common—nearly 10% of American adults have frequent
back pain, for example—and there are many treatments for
it, including rest, regulated exercise (physical therapy), pain-
killing drugs (analgesics), and surgery. However, the best
treatment for any individual depends on the exact nature of
their pain, so it is important to assess their pain carefully
before starting treatment. This is usually done by scoring
overall pain intensity, but this assessment does not reflect
the characteristics of the pain (for example, whether it occurs
spontaneously or in response to external stimuli) or the
complex biological processes involved in pain generation. An
assessment designed to take such factors into account might
improve treatment outcomes and could be useful in the
development of new therapies. In this study, the researchers
develop and test a new, standardized tool for the assessment
of chronic pain that, by examining many symptoms and
signs, aims to distinguish between pain subtypes.
What Did the Researchers Do and Find? One hundred
thirty patients with several types of peripheral neuropathic
pain and 57 patients with non-neuropathic (axial) low back
pain completed a structured interview of 16 questions and a
standardized bedside examination of 23 tests. Patients were
asked, for example, to choose words that described their
pain from a list provided by the researchers and to grade the
intensity of particular aspects of their pain from zero (no
pain) to ten (the maximum imaginable pain). Bedside tests
included measurements of responses to light touch, pinprick,
and vibration—chronic pain often alters responses to
harmless stimuli. Using ‘‘hierarchical cluster analysis,’’ the
researchers identified six subgroups of patients with
neuropathic pain and two subgroups of patients with non-
neuropathic pain based on the patterns of symptoms and
signs revealed by the interviews and physical tests. They
then used ‘‘classification tree analysis’’ to identify the six
questions and ten physical tests that discriminated best
between pain subtypes and combined these items into a
tool for a Standardized Evaluation of Pain (StEP). Finally, the
researchers asked whether StEP, which took 10–15 minutes,
could identify patients with radicular back pain and
discriminate them from those with axial back pain in an
independent group of 137 patients with chronic low back
pain. StEP, they report, accurately diagnosed these two
conditions and was well accepted by the patients.
What Do These Findings Mean? These findings indicate
that a standardized assessment of pain-related signs and
symptoms can provide a simple, quick diagnostic procedure
that distinguishes between radicular (neuropathic) and axial
(non-neuropathic) low back pain. This distinction is crucial
because these types of back pain are best treated in different
ways. In addition, the findings suggest that it might be
possible to identify additional pain subtypes using StEP.
Because these subtypes may represent conditions in which
different pain mechanisms are acting, classifying patients in
this way might eventually enable physicians to tailor
treatments for chronic pain to the specific needs of
individual patients rather than, as at present, largely
guessing which of the available treatments is likely to work
best.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000047.
N This study is further discussed in a PLoS Medicine
Perspective by Giorgio Cruccu and and Andrea Truini
N The US National Institute of Neurological Disorders and
Stroke provides a primer on pain in English and Spanish
N In its 2006 report on the health status of the US, the
National Center for Health Statistics provides a special
feature on the epidemiology of pain, including back pain
N The Pain Treatment Topics Web site is a resource,
sponsored partly by associations and manufacturers, that
provides information on all aspects of pain and its
treatment for health care professionals and their patients
N Medline Plus provides a brief description of pain and of
back pain and links to further information on both topics
(in English and Spanish)
N The MedlinePlus Medical Encyclopedia also has a page on
low back pain (in English and Spanish)
Symptoms and Signs Define Pain Subtypes
PLoS Medicine | www.plosmedicine.org 16 April 2009 | Volume 6 | Issue 4 | e1000047
